These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 33196312)

  • 1. Colchicine for Secondary Cardiovascular Prevention in Coronary Disease.
    Roubille F; Tardif JC
    Circulation; 2020 Nov; 142(20):1901-1904. PubMed ID: 33196312
    [No Abstract]   [Full Text] [Related]  

  • 2. Colchicine in Stable Coronary Artery Disease.
    Fiolet ATL; Nidorf SM; Mosterd A; Cornel JH
    Clin Ther; 2019 Jan; 41(1):30-40. PubMed ID: 30396516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is there a role for colchicine in secondary prevention of coronary artery disease?
    Sudevan R
    Eur J Prev Cardiol; 2022 Feb; 28(17):1914-1915. PubMed ID: 34219144
    [No Abstract]   [Full Text] [Related]  

  • 4. Colchicine and risk of non-cardiovascular death in patients with coronary artery disease: a pooled analysis underling possible safety concerns.
    Galli M; Princi G; Crea F; D'Amario D
    Eur Heart J Cardiovasc Pharmacother; 2021 May; 7(3):e18-e19. PubMed ID: 33270128
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of Acute Colchicine Administration Prior to Percutaneous Coronary Intervention: COLCHICINE-PCI Randomized Trial.
    Shah B; Pillinger M; Zhong H; Cronstein B; Xia Y; Lorin JD; Smilowitz NR; Feit F; Ratnapala N; Keller NM; Katz SD
    Circ Cardiovasc Interv; 2020 Apr; 13(4):e008717. PubMed ID: 32295417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Response-letter to the editor: colchicine and risk of non-cardiovascular death in patients with coronary artery disease: a pooled analysis underlying possible safety concerns.
    Galli M; Princi G; Crea F; D'Amario D
    Eur Heart J Cardiovasc Pharmacother; 2021 Jul; 7(4):e72-e73. PubMed ID: 33725116
    [No Abstract]   [Full Text] [Related]  

  • 7. [Colchicine in patients with coronary heart disease : LoDoCo2 trial].
    Koenig W; Nitschmann S
    Internist (Berl); 2021 Mar; 62(3):333-336. PubMed ID: 33580309
    [No Abstract]   [Full Text] [Related]  

  • 8. Letter to the editor: Colchicine and risk of non-cardiovascular death in patients with coronary artery disease: a pooled analysis underlying possible safety concerns.
    Fiolet ATL; Opstal TSJ; Mosterd A; Eikelboom JW; Nidorf SM; Thompson PL; Budgeon C; Tijssen JGP; Cornel JH
    Eur Heart J Cardiovasc Pharmacother; 2021 Jul; 7(4):e71. PubMed ID: 33713121
    [No Abstract]   [Full Text] [Related]  

  • 9. COLIN trial: Value of colchicine in the treatment of patients with acute myocardial infarction and inflammatory response.
    Akodad M; Lattuca B; Nagot N; Georgescu V; Buisson M; Cristol JP; Leclercq F; Macia JC; Gervasoni R; Cung TT; Cade S; Cransac F; Labour J; Dupuy AM; Roubille F
    Arch Cardiovasc Dis; 2017; 110(6-7):395-402. PubMed ID: 28065445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comment on "Efficacy and safety of colchicine in patients with coronary artery disease: A systematic review and meta-analysis of randomized controlled trials".
    Liang H; Huang D
    Br J Clin Pharmacol; 2022 Jun; 88(6):3000-3001. PubMed ID: 35118689
    [No Abstract]   [Full Text] [Related]  

  • 11. Efficacy and safety of low-dose colchicine in patients with coronary disease: a systematic review and meta-analysis of randomized trials.
    Fiolet ATL; Opstal TSJ; Mosterd A; Eikelboom JW; Jolly SS; Keech AC; Kelly P; Tong DC; Layland J; Nidorf SM; Thompson PL; Budgeon C; Tijssen JGP; Cornel JH
    Eur Heart J; 2021 Jul; 42(28):2765-2775. PubMed ID: 33769515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In patients with CAD, adding colchicine to evidence-based therapies reduces MACE without increasing adverse outcomes.
    Bates ER
    Ann Intern Med; 2021 Mar; 174(3):JC30. PubMed ID: 33646848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meta-analysis Evaluating the Utility of Colchicine in Secondary Prevention of Coronary Artery Disease.
    Xia M; Yang X; Qian C
    Am J Cardiol; 2021 Feb; 140():33-38. PubMed ID: 33137319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lessons from COLCOT and LoDoCo2: colchicine for secondary prevention in coronary artery disease.
    Bouabdallaoui N; Blondeau L; Tardif JC
    Eur Heart J; 2021 Jul; 42(28):2800-2801. PubMed ID: 33496313
    [No Abstract]   [Full Text] [Related]  

  • 15. Why Colchicine Should Be Considered for Secondary Prevention of Atherosclerosis: An Overview.
    Nidorf SM; Thompson PL
    Clin Ther; 2019 Jan; 41(1):41-48. PubMed ID: 30591286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colchicine for acute and chronic coronary syndromes.
    Imazio M; Andreis A; Brucato A; Adler Y; De Ferrari GM
    Heart; 2020 Oct; 106(20):1555-1560. PubMed ID: 32611559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myocardial Infarction With Nonobstructive Coronary Arteries (MINOCA): The Past, Present, and Future Management.
    Pasupathy S; Tavella R; Beltrame JF
    Circulation; 2017 Apr; 135(16):1490-1493. PubMed ID: 28416521
    [No Abstract]   [Full Text] [Related]  

  • 18. Colchicine for stroke prevention in patients with coronary artery disease: a systematic review and meta-analysis.
    Katsanos AH; Palaiodimou L; Price C; Giannopoulos S; Lemmens R; Kosmidou M; Georgakis MK; Weimar C; Kelly PJ; Tsivgoulis G
    Eur J Neurol; 2020 Jun; 27(6):1035-1038. PubMed ID: 32134555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colchicine Use in Acute Coronary Syndromes: An Update.
    Tapoi L; Benchea L; Siriopol D; Kanbay M; Covic A
    Angiology; 2021 Jul; 72(6):503-510. PubMed ID: 33412929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colchicine in the Management of Acute and Chronic Coronary Artery Disease.
    Bouabdallaoui N; Tardif JC
    Curr Cardiol Rep; 2021 Jul; 23(9):120. PubMed ID: 34269908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.